Real-world effects of once-daily inhaled steroid (fluticasone furoate) combined with long-acting beta-2 agonist (vilanterol) and long-acting muscarinic antagonist (umeclidinium) on lung function tests of asthma patients in Japan

Background: The Japanese drug use system allowed the once-daily use of inhaled corticosteroid fluticasone furoate (FF) combined with a long-acting beta-2 agonist vilanterol (VI) and a long-acting muscarinic antagonist umeclidinium (UMEC) against asthma on 18 February 2021. We investigated the real-w...

Descripción completa

Detalles Bibliográficos
Autores principales: Umeda, Akira, Shimada, Hisato, Yamane, Tateki, Mochizuki, Taichi, Inoue, Yasushi, Tsushima, Kenji, Miyagawa, Kazuya, Mochida, Atsumi, Takeda, Hiroshi, Okada, Yasumasa, Masaki, Katsunori, Matsusaka, Masako, Fukunaga, Koichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Physiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10170765/
https://www.ncbi.nlm.nih.gov/pubmed/37179838
http://dx.doi.org/10.3389/fphys.2023.1131949

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10170765/
https://www.ncbi.nlm.nih.gov/pubmed/37179838
http://dx.doi.org/10.3389/fphys.2023.1131949

Ejemplares similares